Predicting ulcerative colitis-associated colorectal cancer using reverse-transcription polymerase chain reaction analysis

Clinical Colorectal Cancer

Volumn 10, Issue 2, 2011, Pages 134-141

  Watanabe, Toshiaki ^a   Kobunai, Takashi ^a,b   Yamamoto, Yoko ^a   Ikeuchi, Hiroki ^c   Matsuda, Keiji ^a   Ishihara, Soichiro ^a   Nozawa, Keijiro ^a   Iinuma, Hisae ^a   Kanazawa, Takamitsu ^d   Tanaka, Toshiaki ^d   Yokoyama, Tadashi ^d   Konishi, Tsuyoshi ^d   Eshima, Kiyoshi ^b   Ajioka, Yohichi ^e   Hibi, Toshifumi ^f   Watanabe, Mamoru ^g   Muto, Tetsuichiro ^h   Nagawa, Hirokazu ^d  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TAIHO PHARMACEUTICAL CO LTD   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e NIIGATA UNIVERSITY   (Japan)

^f KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^h CANCER INSTITUTE HOSPITAL   (Japan)

Author keywords

Dysplasia; Inflammatory bowel disease; Neoplasia; Prediction; RUNX3

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CXCL9 CHEMOKINE; CYCLOSPORIN A; CYP27B1; EDIL3 PROTEIN; ITGB2 PROTEIN; MERCAPTOPURINE; MESALAZINE; NOL3 PROTEIN; ONCOPROTEIN; PROTEIN KINASE LYN; SAMSN1 PROTEIN; TRANSCRIPTION FACTOR RUNX3; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER RISK; CARCINOGENESIS; CLINICAL ASSESSMENT; COLITIS; COLONOSCOPY; COLORECTAL CANCER; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PREDICTIVE VALUE; PRIMARY SCLEROSING CHOLANGITIS; PROCTITIS; PROCTOSIGMOIDITIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULCERATIVE COLITIS;

EID: 79959326755     PISSN: 15330028     EISSN: 19380674     Source Type: Journal    
DOI: 10.1016/j.clcc.2011.03.011     Document Type: Article

References (37)

1. Riddell RH, Goldman H, Ransohoff DF, et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 1983; 14:931-68.
2. Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001; 48:526-35. (Pubitemid 32234798)
3. Hata K, Watanabe T, Kazama S, et al. Earlier surveillance colonoscopy programme improves survival in patients with ulcerative colitis associated colorectal cancer: results of a 23-year surveillance programme in the Japanese population. Br J Cancer 2003; 89:1232-6. (Pubitemid 37363409)
4. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectaltumor development. N Engl J Med 1988; 319:525-32.
5. Brentnall TA, Crispin DA, Rabinovitch PS, et al. Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Gastroenterology 1994; 107:369-78. (Pubitemid 24233310)
6. Tarmin L, Yin J, Harpaz N, et al. Adenomatous polyposis coli gene mutations in ulcerative colitis-associated dysplasias and cancers versus sporadic colon neoplasms. Cancer Res 1995; 55:2035-8.
7. Hsieh CJ, Klump B, Holzmann K, et al. Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis. Cancer Res 1998; 58:3942-5. (Pubitemid 28405652)
8. Sato F, Harpaz N, Shibata D, et al. Hypermethylation of the p14 (ARF) gene in ulcerative colitis-associated colorectal carcinogenesis. Cancer Res 2002; 62:1148-51. (Pubitemid 34160301)
9. Issa JP, Ahuja N, Toyota M, et al. Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res 2001; 61:3573-7. (Pubitemid 32694963)
10. Brentnall TA, Crispin DA, Bronner MP, et al. Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis. Cancer Res 1996; 56: 1237-40. (Pubitemid 26080961)
11. Fujii S, Tominaga K, Kitajima K, et al. Methylation of the oestrogen receptor gene in non-neoplastic epithelium as a marker of colorectal neoplasia risk in longstanding and extensive ulcerative colitis. Gut 2005; 54:1287-92. (Pubitemid 41192492)
12. Xie J, Itzkowitz SH. Cancer in inflammatory bowel disease. World J Gastroenterol 2008; 14:378-89. (Pubitemid 351320846)
13. Watanabe T, Kobunai T, Toda E, et al. Gene expression signature and the prediction of ulcerative colitis-associated colorectal cancer by DNA microarray. Clin Cancer Res 2007; 13:415-20. (Pubitemid 46225344)
14. Ding Y, Xu L, Jovanovic BD, et al. The methodology used to measure differential gene expression affects the outcome. J Biomol Tech 2007; 18:321-30.
15. Lossos IS, Czerwinski DK, Alizadeh AA, et al. Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes. N Engl J Med 2004; 350:1828-37. (Pubitemid 38917249)
16. Chen HY, Yu SL, Chen CH, et al. A five-gene signature and clinical outcome in non-small-cell lung cancer. N Engl J Med 2007; 356:11-20.
17. Endoh H, Tomida S, Yatabe Y, et al. Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reaction. J Clin Oncol 2004; 22:811-9. (Pubitemid 41103592)
18. Chen CN, Lin JJ, Chen JJ, et al. Gene expression profile predicts patient survival of gastric cancer after surgical resection. J Clin Oncol 2005; 23:7286-95. (Pubitemid 46202342)
19. Camos M, Esteve J, Jares P, et al. Gene expression profiling of acute myeloid leukemia with translocation t(8;16)(p11;p13) and MYST3-CREBBP rearrangement reveals a distinctive signature with a specific pattern of HOX gene expression. Cancer Res 2006; 66:6947-54. (Pubitemid 44197669)
20. Bonanomi A, Kojic D, Giger B, et al. Quantitative cytokine gene expression in human tonsils at excision and during histoculture assessed by standardized and calibrated real-time PCR and novel data processing. J Immunol Methods 2003; 283:27-43. (Pubitemid 37505014)
21. Pérez S, Royo LJ, Astudillo A, et al. Identifying the most suitable endogenous control for determining gene expression in hearts from organ donors. BMC Mol Biol 2007; 8:114.
22. Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3:RESEARCH0034.
23. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (T)(-Delta Delta C) method. Methods 2001; 25:402-8. (Pubitemid 34164012)
24. Green GH, Diggle PJ. On the operational characteristics of the Benjamini and Hochberg false discovery rate procedure. Stat Appl Genet Mol Biol 2007; 6:Article27
25. Brown MP, Grundy WN, Lin D, et al. Knowledge-based analysis of microarray gene expression data by using support vector machines. Proc Natl Acad Sci U S A 2000; 97:262-7. (Pubitemid 30055819)
26. Yamada H, Yanagisawa K, Tokumaru S, et al. Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at 21q11-21 in human lung cancer. Genes Chromosomes Cancer 2008; 47:810-8.
27. Luo JH, Ren B, Keryanov S, et al. Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas. Hepatology 2006; 44:1012-24. (Pubitemid 46489565)
28. Beilstein MA, Vendeland SC, Barofsky E, et al. SelenoproteinWof rat muscle binds glutathione and an unknown small molecular weight moiety. J Inorg Biochem 1996; 61:117-24. (Pubitemid 26049899)
29. Hu Y, Sun H, Drake J, et al. From mice to humans: identification of commonly deregulated genes in mammary cancer via comparative SAGE studies. Cancer Res 2004; 64:7748-55. (Pubitemid 39446906)
30. Mercier I, Vuolo M, Jasmin JF, et al. ARC (apoptosis repressor with caspase recruitment domain) is a novel marker of human colon cancer. Cell Cycle 2008; 7:1640-7. (Pubitemid 351881332)
31. Ogunkolade BW, Boucher BJ, Fairclough PD, et al. Expression of 25-hydroxyvitamin D-1-alpha-hydroxylase mRNA in individuals with colorectal cancer. Lancet 2002; 359:1831-2. (Pubitemid 34607061)
32. Lau QC, Raja E, Salto-Tellez M, et al. RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer. Cancer Res 2006; 66:6512-20. (Pubitemid 44085605)
33. Fukamachi H, Ito K. Growth regulation of gastric epithelial cells by Runx3. Oncogene 2004; 23:4330-5. (Pubitemid 38758598)
34. Li QL, Ito K, Sakakura C, et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 2002; 109:113-24. (Pubitemid 34327521)
35. Erreni M, Bianchi P, Laghi L, et al. Expression of chemokines and chemokine receptors in human colon cancer. Methods Enzymol 2009; 460:105-21.
36. Cavalieri D, Dolara P, Mini E, et al. Analysis of gene expression profiles reveals novel correlations with the clinical course of colorectal cancer. Oncol Res 2007; 16:535-48. (Pubitemid 351211326)
37. Goldenberg-Furmanov M, Stein I, Pikarsky E, et al. Lyn is a target gene for prostate cancer: sequence-based inhibition induces regression of human tumor xenografts. Cancer Res 2004; 64:1058-66. (Pubitemid 38176910)